DIMERIX LIMITED — Investor Relations & Filings
Dimerix Limited focuses on the development of therapeutic treatments for inflammatory diseases, with a primary emphasis on kidney and respiratory conditions. The company utilizes its proprietary Receptor-Heteromer Investigation Technology (DMX-Technology) to identify and validate G protein-coupled receptor (GPCR) targets. Its lead candidate, DMX-200, is a chemokine receptor (CCR2) antagonist currently in Phase 3 clinical trials for the treatment of Focal Segmental Glomerulosclerosis (FSGS). The company is also advancing DMX-700 for Chronic Obstructive Pulmonary Disease (COPD) and exploring applications for diabetic kidney disease. The core strategy involves targeting multiple signaling pathways simultaneously to address unmet medical needs in chronic inflammatory and fibrotic diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Dimerix Quarterly Activities Report and Appendix 4C 10 pages 600.1KB | 2026-04-29 | English | |
| ACTION3 Statistical Review Complete 4 pages 440.7KB | 2026-04-27 | English | |
| Dimerix Releases Investor Presentation and Video Recording 26 pages 3.5MB | 2026-04-27 | English | |
| Dimerix Singapore Investor Briefing 2 pages 346.1KB | 2026-04-08 | English | |
| Dimerix to Conduct Review of ACTION3 Statistical Assumptions 3 pages 390.7KB | 2026-03-15 | English | |
| Dimerix Presents at Euroz Hartleys Institutional Conference 28 pages 3.8MB | 2026-03-15 | English |
Browse filings by year
24 years- 2026 14 filings
- 2024 113 filings
- 2023 91 filings
- 2022 40 filings
- 2021 70 filings
- 2020 56 filings
- 2019 41 filings
- 2018 55 filings
- 2017 78 filings
- 2016 52 filings
- 2015 3 filings
- 2014 34 filings
- 2013 41 filings
- 2012 28 filings
- 2011 15 filings
- 2010 45 filings
- 2009 66 filings
- 2008 81 filings
- 2007 4 filings
- 2006 63 filings
- 2005 63 filings
- 2004 36 filings
- 2003 31 filings
- 2002 4 filings
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
SYNTARA LIMITED
Clinical-stage developer of small molecule drugs for inflam…
|
SNT | AU | Professional, scientific and te… |
|
SyntekaBio,Inc.
An AI-driven drug discovery company using supercomputing to…
|
226330 | KR | Professional, scientific and te… |
|
Take Solutions Ltd
Provides specialized domain-led technology and services for…
|
TAKE | IN | Professional, scientific and te… |
|
Tango Therapeutics, Inc.
A clinical-stage biotech developing precision oncology medi…
|
TNGX | US | Professional, scientific and te… |
|
Taysha Gene Therapies, Inc.
Clinical-stage company developing AAV-based gene therapies …
|
TSHA | US | Professional, scientific and te… |
|
Technical Ventures RX Corp.
Develops and commercializes autologous cell therapies for t…
|
— | CA | Professional, scientific and te… |
|
Tectonic Therapeutic, Inc.
Clinical-stage biotech developing biologics targeting G-Pro…
|
TECX | US | Professional, scientific and te… |
|
Telo Genomics Corp.
Quantifies genomic instability via telomere 3D structure to…
|
TELO | CA | Professional, scientific and te… |
|
Telomir Pharmaceuticals, Inc.
Pre-clinical pharma company developing a small molecule for…
|
TELO | US | Professional, scientific and te… |
|
Tempest Therapeutics, Inc.
Clinical-stage oncology company developing small molecule a…
|
TPST | US | Professional, scientific and te… |
DIMERIX LIMITED via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/64804/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=64804 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=64804 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=64804 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 64804}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for DIMERIX LIMITED (id: 64804)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.